Filing Details

Accession Number:
0001144204-14-062005
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-20 18:29:01
Reporting Period:
2014-09-26
Filing Date:
2014-10-20
Accepted Time:
2014-10-20 17:29:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1379006 Nanoviricides Inc. NNVC Services-Commercial Physical & Biological Research (8731) 760674577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1580568 Milton Boniuk C/O Nanoviricides, Inc.
135 Wood Street, Suite 205
West Haven CT 06516
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2014-09-26 3,167 $3.20 662,130 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-09-29 15,841 $3.20 677,921 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-09-30 19,300 $3.16 697,271 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-09-30 30,300 $3.00 727,571 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-09-30 11,692 $3.15 739,263 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-10-01 1,200 $3.10 740,463 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2014-10-01 18,500 $3.10 758,963 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Held by the Reporting Person and his wife. Does not include warrants to purchase an additional 542,856 shares of common stock held by the Reporting Person and his wife. Does not include: 190,477 shares of common stock held by the Boniuk Charitable Foundation; 314,286 shares of common stock and warrants to purchase 257,142 shares of common stock currently exercisable or an indeterminate number of shares of common stock issuable upon conversion of debentures held by Boniuk Interests Ltd.; or 952,381 shares of common stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.